Nicotine - Older Adults (50+): Difference between revisions

Line 39: Line 39:
***Acknowledgement: This research was supported by grant U54CA229974 from the NCI and FDA Center for Tobacco Products (all authors) and grant U01CA253858 from the NCI (Drs Meza, Cao, Jeon, and Levy).
***Acknowledgement: This research was supported by grant U54CA229974 from the NCI and FDA Center for Tobacco Products (all authors) and grant U01CA253858 from the NCI (Drs Meza, Cao, Jeon, and Levy).


===2021: Paper: [https://tobaccocontrol.bmj.com/content/early/2021/08/12/tobaccocontrol-2021-056945 Ignoring our elders: tobacco control’s forgotten health equity issue]===
===2021: [https://tobaccocontrol.bmj.com/content/early/2021/08/12/tobaccocontrol-2021-056945 Ignoring our elders: tobacco control’s forgotten health equity issue]===
*Those who suffer multiple forms of stigmatisation and feel devalued in society find it harder than higher status, socially valued individuals to change health behaviours, lacking resources and social encouragement to do so. The deprioritisation of older smokers is a symptom of institutionalised ageism, which must be addressed systematically to apply the tenets of health equity and inclusion in our work. Across all areas of tobacco control, we must do better by our elders.
*Those who suffer multiple forms of stigmatisation and feel devalued in society find it harder than higher status, socially valued individuals to change health behaviours, lacking resources and social encouragement to do so. The deprioritisation of older smokers is a symptom of institutionalised ageism, which must be addressed systematically to apply the tenets of health equity and inclusion in our work. Across all areas of tobacco control, we must do better by our elders.
**Citation: McAfee T, Malone RE, Cataldo J, Ignoring our elders: tobacco control’s forgotten health equity issue. Tobacco Control 2021;30:479-480.
**Citation: McAfee T, Malone RE, Cataldo J, Ignoring our elders: tobacco control’s forgotten health equity issue. Tobacco Control 2021;30:479-480.
Line 59: Line 59:
**Source: Beth Brophy, ''AARP''
**Source: Beth Brophy, ''AARP''


===2011: Paper: [https://jamanetwork.com/journals/jama/article-abstract/1104250 The Older Smoker]===
===2011: [https://jamanetwork.com/journals/jama/article-abstract/1104250 The Older Smoker]===
*Understanding how these age-related differences impact smoking-related outcomes (eg, tobacco withdrawal, acute effects of smoking, treatment efficacy) is limited because research examining older smokers is lacking. In a systematic review of tobacco withdrawal symptoms, the mean (SD) age of participants across 15 studies, chosen for their scientific rigor, was 37.8 (8.1) years.
*Understanding how these age-related differences impact smoking-related outcomes (eg, tobacco withdrawal, acute effects of smoking, treatment efficacy) is limited because research examining older smokers is lacking. In a systematic review of tobacco withdrawal symptoms, the mean (SD) age of participants across 15 studies, chosen for their scientific rigor, was 37.8 (8.1) years.
*[https://sci-hub.st/10.1001/jama.2011.1221 PDF Full Paper]
*[https://sci-hub.st/10.1001/jama.2011.1221 PDF Full Paper]